Temporal pattern of C1q deposition after transient focal cerebral ischemia

Journal of Neuroscience Research

Volumn 83, Issue 5, 2006, Pages 883-889

  Mack, William J ^a,c   Sughrue, Michael E ^a   Ducruet, Andrew F ^a   Mocco, J ^a   Sosunov, Sergey A ^a   Hassid, Benjamin G ^a   Silverberg, Joshua Z ^a   Ten, Vadim S ^a   Pinsky, David J ^b   Connolly Jr , E Sander ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

C1q; Cerebral ischemia; Complement; Mouse; Neuroprotection; Reperfusion injury

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL DAMAGE; CELL DEATH; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HEMISPHERE; MALE; MICROSCOPY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING; STROKE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; COMPLEMENT C1Q; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NEURONS; TIME FACTORS;

EID: 33645304849     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20775     Document Type: Article

References (26)

1. Belayev L, Busto R, Zhao W, Ginsberg MD. 1996. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739:88-96.
2. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56-59.
3. Chakraborti T, Mandal A, Mandal M, Das S, Chakraborti S. 2000. Complement activation in heart diseases. Role of oxidants. Cell Signal 12:607-617.
4. Collard CD, Vakeva A, Bukusoglu C, Zund G, Sperati CJ, Colgan SP, Stahl GL. 1997. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96:326-333.
5. Connolly ES Jr, Winfree CJ, Stern DM, Solomon RA, Pinsky DJ. 1996. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 38:523-531; discussion 532.
6. D'Ambrosio AL, Pinsky DJ, Connolly ES. 2001. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med 7:367-382.
7. Fagan SC, Hess DC, Machado LS, Hohnadel EJ, Pollock DM, Ergul A. 2005. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy 25:387-395.
8. Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP. 2000. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49:171-186.
9. Gasque P, Ischenko A, Legoedec J, Mauger C, Schouft MT, Fontaine M. 1993. Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells. J Biol Chem 268:25068-25074.
10. Gasque P, Julen N, Ischenko AM, Picot C, Mauger C, Chauzy C, Ripoche J, Fontaine M. 1992. Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 149:1381-1387.
11. Gladstone DJ, Black SE, Hakim AM. 2002. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-2136.
12. Huang J, Kim LJ, Mealey R, Marsh HC Jr, Zhang Y, Tenner AJ, Connolly ES Jr, Pinsky DJ. 1999. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285:595-599.
13. Kagiyama A, Savage HE, Michael LH, Hanson G, Entman ML, Rossen RD. 1989. Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement. Circ Res 64:607-615.
14. Loos M. 1983. Biosynthesis of the collagen-like C1q molecule and its receptor functions for Fc and polyanionic molecules on macrophages. Curr Top Microbiol Immunol 102:1-56.
15. Morgan BP, Gasque P. 1996. Expression of complement in the brain: role in health and disease. Immunol Today 17:461-466.
16. Morgan BP, Gasque P. 1997. Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 107:1-7.
17. Reid K, Porter RR. 1976. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 155:19-23.
18. Rossen R, Michael LH, Kagiyama A, Savage HE, Hanson G, Reisberg MA, Moake JN, Kim SH, Self D, Weakley S. 1988. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ Res 62:572-584.
19. Schafer MK, Schwaeble WJ, Post C, Salvati P, Calabresi M, Sim RB, Petry F, Loos M, Weihe E. 2000. Complement C1q is dramatically upregulated in brain microglia in response to transient global cerebral ischemia. J Immunol 164:5446-5452.
20. Tenner AJ. 2001. Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging 22:849-861.
21. Vakeva A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. 1994. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144:1357-1368.
22. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97:2259-2267.
23. van Beek J, Elward K, Gasque P. 2003. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann NY Acad Sci 992:56-71.
24. Wada K, Montalto MC, Stahl GL. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 120:126-133.
25. Zhao H, Montalto MC, Pfeifler KJ, Hao L, Stahl GL. 2002. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J Appl Physiol 93:338-345.
26. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH. 2000. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105:1363-1371.